improve study update: safety and efficacy of venetoclax retreatment in r/r cll
Published 1 year ago • 118 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:51
the safety and efficacy of retreatment with venetoclax plus rituximab in r/r cll
-
3:17
transcend-cll-004 study update: safety and efficacy of liso-cel in r/r cll
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
2:01
the evolution of bcl2 inhibition in cll
-
1:11
treatment options for patients with cll after failure of covalent btk inhibitors and venetoclax
-
4:38
venice i: venetoclax in r/r cll patients
-
1:09
current and emerging treatment strategies for cll & defining the optimal treatment duration
-
1:25
strategies to improve the efficacy of car-ts in cll
-
1:09
sequencing of therapies to improve outcomes of cll patients
-
1:42
the future of cll treatment: aiming for long-lasting remission
-
2:25
a final update of enhance: reflecting on the negative read-out of the study
-
1:28
the future of cll treatment
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
1:41
refining and improving treatment options in cll
-
1:12
developing safe and effective agents for the treatment of cll
-
4:26
transcend-cll-004: lisocabtagene maraleucel in cll
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
1:07
key advancements in the treatment of bpdcn from ebmt 2024
-
0:53
the future of cll treatment